Venugopalan Muralidharan

Venugopalan Muralidharan is a declared insider of Aurobindo Pharma Limited, with filings sourced from SEBI (PIT + SAST). We count 2 filings; the first trade dates from 15 November 2021 and the latest from 29 September 2023.

The open-market side counts 1 purchase for €41k alongside 1 sale for €63k. Netting one side against the other leaves €22k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2023 alone, the filings show no purchases and 1 sale.

Most recently, on 30 September 2023, the filings show an open-market sale worth €63k in Aurobindo Pharma Limited. The last purchase on record was published on 17 November 2021, which is 1,818 days ago. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.